These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 19888533

  • 21. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P, Nielsen VG, Armstead V, Powell G, Kim J, Kim L, Mehta M.
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [Abstract] [Full Text] [Related]

  • 22. The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease.
    Opstad TB, Pettersen AA, Bratseth V, Arnesen H, Seljeflot I.
    Pathophysiol Haemost Thromb; 2010 Oct; 37(2-4):98-103. PubMed ID: 21555871
    [Abstract] [Full Text] [Related]

  • 23. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S, Sandset PM, Jacobsen EM, Mowinckel MC, Wisløff F.
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [Abstract] [Full Text] [Related]

  • 24. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M, Wada H, Wakita Y, Nakase T, Hiyoyama K, Nagaya S, Mori Y, Shiku H.
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [Abstract] [Full Text] [Related]

  • 25. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M, Zekanowska E, Uszyński W, Kuczyński J, Zyliński A.
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [Abstract] [Full Text] [Related]

  • 26. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M, Morishita E, Asakura H, Jokaji H, Uotani C, Kumabashiri I, Yamazaki M, Aoshima K, Matsuda T.
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [Abstract] [Full Text] [Related]

  • 27. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
    Ho CC, Tong SF, Low WY, Ng CJ, Khoo EM, Lee VK, Zainuddin ZM, Tan HM.
    BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057
    [Abstract] [Full Text] [Related]

  • 28. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
    Morange PE, Renucci JF, Charles MA, Aillaud MF, Giraud F, Grimaux M, Juhan-Vague I.
    Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
    [Abstract] [Full Text] [Related]

  • 29. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status.
    Haren M, Chapman I, Coates P, Morley J, Wittert G.
    Age Ageing; 2005 Mar; 34(2):125-30. PubMed ID: 15596419
    [Abstract] [Full Text] [Related]

  • 30. Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate.
    Yassin AA, Saad F.
    Andrologia; 2007 Oct; 39(5):181-4. PubMed ID: 17714216
    [Abstract] [Full Text] [Related]

  • 31. Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man.
    Hansen JB, Sandset PM, Huseby KR, Huseby NE, Nordøy A.
    Thromb Haemost; 1996 Nov; 76(5):703-9. PubMed ID: 8950777
    [Abstract] [Full Text] [Related]

  • 32. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
    Zhu Y, Xie ZX, He XF, Han JZ, Li JC, He SL.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug 28; 25(4):401-2, 405. PubMed ID: 12206017
    [Abstract] [Full Text] [Related]

  • 33. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD, Amory JK, Herbst KL, Coviello AD, Page ST, Bremner WJ, Matsumoto AM.
    J Androl; 2005 Aug 28; 26(3):405-13. PubMed ID: 15867009
    [Abstract] [Full Text] [Related]

  • 34. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
    Moisey R, Swinburne J, Orme S.
    Clin Endocrinol (Oxf); 2008 Oct 28; 69(4):642-7. PubMed ID: 18394021
    [Abstract] [Full Text] [Related]

  • 35. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S, Hiramatsu Y, Matsuzaki K, Goto Y, Sato S, Abe M, Kato H, Matsubara M, Sakakibara Y.
    J Card Surg; 2014 Jan 28; 29(1):35-40. PubMed ID: 24266905
    [Abstract] [Full Text] [Related]

  • 36. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M, Wada H, Wakita Y, Shimura M, Nakase T, Hiyoyama K, Nagaya S, Minami N, Nakano T, Shiku H.
    Thromb Haemost; 1995 Jan 28; 73(1):10-4. PubMed ID: 7740478
    [Abstract] [Full Text] [Related]

  • 37. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M, Ranlall N, Patel G, Rutlin A, Jehanli A, Kakkar VV.
    Blood Coagul Fibrinolysis; 2000 Apr 28; 11(3):285-91. PubMed ID: 10870809
    [Abstract] [Full Text] [Related]

  • 38. [Effects of tissue factor pathway inhibitor-1 on no-reflow in a rabbit model].
    Luo JG, Chen YD, Tian F, Wang CH, Lü Y, Yang XX, Lü SZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec 28; 37(12):1113-8. PubMed ID: 20193184
    [Abstract] [Full Text] [Related]

  • 39. Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy.
    Ittel A, Bretelle F, Gris JC, Chau C, Sébahoun G, Boubli L, Arnoux D.
    Thromb Haemost; 2011 Jan 28; 105(1):66-71. PubMed ID: 20978710
    [Abstract] [Full Text] [Related]

  • 40. Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
    Pawlak K, Tankiewicz J, Mysliwiec M, Pawlak D.
    Blood Coagul Fibrinolysis; 2009 Oct 28; 20(7):590-4. PubMed ID: 19491664
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.